Ishares Msci Spain ETF vs IDEXX Laboratories, Inc. — how do they compare? Ishares Msci Spain ETF trades at $57.87 (market cap $2.30B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 17.6× Ishares Msci Spain ETF's market cap, and Ishares Msci Spain ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Spain ETF for 41 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| EWP | IDXX | |
|---|---|---|
Market Cap | $2.30B | $40.43B |
Volume | 845,747 | 692,164 |
Sector | Broad Market / Factor | Health |
52-Week High | $63.23 | $766.68 |
52-Week Low | $48.33 | $504.70 |
Typical Hold Time | 41 Days | 46 Days |
Enterprise Value | — | $41.32B |
Signals from Pluang's Aura AI — not financial advice
EWP, the iShares MSCI Spain ETF, trades at $57.90 with minimal daily movement (+0.14%). Technical indicators show a bearish trend with strong selling pressure across moving averages and oscillators. The ETF offers exposure to Spanish equities at a discounted valuation with a 2.7% yield, though concentrated in financials and utilities. Recent ECB rate hikes and energy price volatility create macroeconomic headwinds for European markets.
The outlook remains cautious given bearish technical signals and eurozone economic pressures. Attractive valuation and dividend yield provide support, but concentration risk and monetary policy tightening pose challenges. Further upside depends on Spanish economic resilience and stabilization of energy inflation.
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →